Cargando…
Application of WeChat Platform in Midterm Clinical Follow-Up of Children Who Underwent Transthoracic Device Closure of VSD
INTRODUCTION: The purpose of this study was to investigate the feasibility and superiority of using the WeChat platform for midterm clinical follow-up of children who underwent transthoracic device closure for ventricular septal defects (VSDs). METHODS: Ninety children with VSDs who underwent transt...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Cirurgia Cardiovascular
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9054152/ https://www.ncbi.nlm.nih.gov/pubmed/33656834 http://dx.doi.org/10.21470/1678-9741-2020-0376 |
_version_ | 1784697132477841408 |
---|---|
author | Xie, Wen-Peng Liu, Jian-Feng Lei, Yu-Qing Wang, Zeng-Chun Chen, Qiang Cao, Hua |
author_facet | Xie, Wen-Peng Liu, Jian-Feng Lei, Yu-Qing Wang, Zeng-Chun Chen, Qiang Cao, Hua |
author_sort | Xie, Wen-Peng |
collection | PubMed |
description | INTRODUCTION: The purpose of this study was to investigate the feasibility and superiority of using the WeChat platform for midterm clinical follow-up of children who underwent transthoracic device closure for ventricular septal defects (VSDs). METHODS: Ninety children with VSDs who underwent transthoracic device closure were divided into a WeChat follow-up group (WFU group) and an outpatient follow-up group (OFU group). The patients were followed up via WeChat or at an outpatient clinic three months and one year after discharge. The incidences of adverse events, associated complications, costs and time spent, loss to follow-up rate, medication adherence, and overall satisfaction were recorded. RESULTS: There was no statistically significant difference in the incidence of adverse events or postoperative complications between the two groups. Also, the loss to follow-up rate was similar between them. Compared with the OFU group, there were significant statistical advantages in the WFU group regarding the total time and cost spent, medication adherence, and satisfaction. CONCLUSION: The use of the WeChat platform in midterm clinical follow-up of children who underwent transthoracic device closure for VSDs has the advantages of reducing financial and time burdens, facilitating high medication adherence, and leading to high satisfaction. |
format | Online Article Text |
id | pubmed-9054152 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Sociedade Brasileira de Cirurgia Cardiovascular |
record_format | MEDLINE/PubMed |
spelling | pubmed-90541522022-05-02 Application of WeChat Platform in Midterm Clinical Follow-Up of Children Who Underwent Transthoracic Device Closure of VSD Xie, Wen-Peng Liu, Jian-Feng Lei, Yu-Qing Wang, Zeng-Chun Chen, Qiang Cao, Hua Braz J Cardiovasc Surg Original Article INTRODUCTION: The purpose of this study was to investigate the feasibility and superiority of using the WeChat platform for midterm clinical follow-up of children who underwent transthoracic device closure for ventricular septal defects (VSDs). METHODS: Ninety children with VSDs who underwent transthoracic device closure were divided into a WeChat follow-up group (WFU group) and an outpatient follow-up group (OFU group). The patients were followed up via WeChat or at an outpatient clinic three months and one year after discharge. The incidences of adverse events, associated complications, costs and time spent, loss to follow-up rate, medication adherence, and overall satisfaction were recorded. RESULTS: There was no statistically significant difference in the incidence of adverse events or postoperative complications between the two groups. Also, the loss to follow-up rate was similar between them. Compared with the OFU group, there were significant statistical advantages in the WFU group regarding the total time and cost spent, medication adherence, and satisfaction. CONCLUSION: The use of the WeChat platform in midterm clinical follow-up of children who underwent transthoracic device closure for VSDs has the advantages of reducing financial and time burdens, facilitating high medication adherence, and leading to high satisfaction. Sociedade Brasileira de Cirurgia Cardiovascular 2022 /pmc/articles/PMC9054152/ /pubmed/33656834 http://dx.doi.org/10.21470/1678-9741-2020-0376 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Xie, Wen-Peng Liu, Jian-Feng Lei, Yu-Qing Wang, Zeng-Chun Chen, Qiang Cao, Hua Application of WeChat Platform in Midterm Clinical Follow-Up of Children Who Underwent Transthoracic Device Closure of VSD |
title | Application of WeChat Platform in Midterm Clinical Follow-Up of Children Who Underwent Transthoracic Device Closure of VSD |
title_full | Application of WeChat Platform in Midterm Clinical Follow-Up of Children Who Underwent Transthoracic Device Closure of VSD |
title_fullStr | Application of WeChat Platform in Midterm Clinical Follow-Up of Children Who Underwent Transthoracic Device Closure of VSD |
title_full_unstemmed | Application of WeChat Platform in Midterm Clinical Follow-Up of Children Who Underwent Transthoracic Device Closure of VSD |
title_short | Application of WeChat Platform in Midterm Clinical Follow-Up of Children Who Underwent Transthoracic Device Closure of VSD |
title_sort | application of wechat platform in midterm clinical follow-up of children who underwent transthoracic device closure of vsd |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9054152/ https://www.ncbi.nlm.nih.gov/pubmed/33656834 http://dx.doi.org/10.21470/1678-9741-2020-0376 |
work_keys_str_mv | AT xiewenpeng applicationofwechatplatforminmidtermclinicalfollowupofchildrenwhounderwenttransthoracicdeviceclosureofvsd AT liujianfeng applicationofwechatplatforminmidtermclinicalfollowupofchildrenwhounderwenttransthoracicdeviceclosureofvsd AT leiyuqing applicationofwechatplatforminmidtermclinicalfollowupofchildrenwhounderwenttransthoracicdeviceclosureofvsd AT wangzengchun applicationofwechatplatforminmidtermclinicalfollowupofchildrenwhounderwenttransthoracicdeviceclosureofvsd AT chenqiang applicationofwechatplatforminmidtermclinicalfollowupofchildrenwhounderwenttransthoracicdeviceclosureofvsd AT caohua applicationofwechatplatforminmidtermclinicalfollowupofchildrenwhounderwenttransthoracicdeviceclosureofvsd |